Charcot Joint Disease in Diabetes Mellitus

Annals of Vascular Surgery

Volumn 17, Issue 5, 2003, Pages 571-580

  Lee, Lieke ^a   Blume, Peter A ^a,c   Sumpio, Bauer ^b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LEUKOCYTE IN 111;

ANHIDROSIS; ARTHRODESIS; BLOOD FLOW; BONE BIOPSY; BONE SCINTISCANNING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DIABETIC FOOT; DISEASE DURATION; EARLY DIAGNOSIS; FOOT MALFORMATION; FOOT RADIOGRAPHY; HUMAN; JOINT BIOPSY; NEUROPATHIC JOINT DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSIS; OSTEOMYELITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WALKING AID;

EID: 0242626526     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-003-0039-5     Document Type: Review

References (39)

1. Sumpio BE. Foot ulcers. N Engl J Med 2000;343:787-793.
2. Wilson M. Charcot foot osteoarthropathy in diabetes mellittus. Mil Med 1991;156:563-569.
3. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999;38:34-40.
4. Knox R, Dutch W, Blume P, Sumpio B. Diabetic foot disease. Int J Angiol 2000;9:1-6.
5. Cofield RH, Motrisin MJ, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic changes. Foot Ankle 1983;4:15-22.
6. Brower AC, Allman RM. Pathogenesis of neurotrophic joint: neurotraumatic vs. neurovascular. Radiology 1981;139:349-354.
7. Allman RM, Brower AC, Kotlyarov EB. Neuropathic bone and joint disease. Radiol Clin North Am 1988;26:1373-1381.
8. Rosenblatt HM, Coleman SS. Charcot spine. Q Bull North-western Univ Med School 1956;30:309-314.
9. Archer AG, Roberts VC, Watkins PJ. Blood flow patterns in painful diabetic neuropathy. Diabetologia 1984;27:563-567.
10. Edmonds ME, Roberts VC, Watkins P. Blood flow in the diabetic neuropathic foot. Diabetologia 1982;22:9-15.
11. Delano PJ. The pathogenesis of Charcot joint. AJR Am J Roentgenol 1946;56:189-200.
12. Eloesser L. On the nature of neuropathic affections of the joints. Ann Surg 1917;66:201-207.
13. Gupta R. A short history of neuropathic arthropathy. Clin Orthop Rel Res 1993;296:43-49.
14. Bruckner FE, Howell A. Neuropathic joints. Semin Arthritis Rheum 1972;2:47-69.
15. Schon LC, Easley ME, Weinfeld SB. Charcot neuroarthropathy of the foot and ankle. Clin Orthop Rel Res 1998;349:116-131.
16. Reiner M, et al. The neuropathic joint in diabetes mellitus. Clin Podiatr Med Surg 1988;5:421-437.
17. Ellenberg M. Diabetic neuropathy. Diabetes 1982;8:1.
18. Sequeira W. The neuropathic joint. Clin Exp Rheumatol 1994;12:325-337.
19. Sanders LJ, Frykberg RG. Charcot foot. The Diabetic Foot, 5th ed. St. Louis: Mosby Yearbook, 1993, pp 149-180.
20. Banks AS, McGlamry ED. Charcot foot. J Am Podiatr Med Assoc 1989;79:213-235.
21. Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg 1998;80-A:365-369.
22. Grant W, et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg 1997;36:272-278.
23. Lipman BT, et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI, and conventional radiography. Clin Nucl Med 1998;23:77-82.
24. Beltran J, et al. The diabetic foot: magnetic resonance imaging evaluation. Skeletal Radiol 1990;19:37-41.
25. Devillers A, et al. Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med 1998;25:132-138.
26. Blume PA, et al. Diagnosis of pedal osteomyelitis in Tc-99m HMPAO labeled leukocytes. J Foot Ankle Surg 1997;36:120-126.
27. Palestro CJ, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998;39:346-350.
28. Schon LC, Marks RM. The management of neuroarthropathic fracture-dislocations in the diabetic patients. Orthop Clin North Am 1995;26:375-392.
29. Lavery LA, Armstrong DG, Walker SC. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot's arthropathy. Diabet Med 1997;14:46-49.
30. Lavery LA, et al. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;158:157-162.
31. Saltzman CL, et al. The patellar tendon-bearing brace as treatment for neuropathic arthropathy: a dynamic force monitoring study. Foot Ankle 1992;13:14-21.
32. Armstrong DG, et al. The natural history of acute Charcot's arthropathy in the diabetic foot specialty clinic. J Am Podiatr Med Assoc 1997;87:272-278.
33. Baker RE. Total contact casting. J Am Podiatr Med Assoc 1995;85:172-176.
34. Boninger ML, Leonard JA. Use of bivalved ankle-foot orthosis in neuropathic foot and ankle lesions. J Rehab Res Dev 1996;33:16-22.
35. Morgan JM, Biehl WC, Wagner FW. Management of neuropathic arthropathy with the Charcot restraint orthotic walker. Clin Orthop Rel Res 1993;296:58-63.
36. Lavery LA, et al. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;158:157-162 .
37. Berend ME, Glisson RR, Manley JA. A biomechanical comparison of IM and crossed lag screw for tibiot-alocalcaneal arthrodesis. Foot Ankle Int 1997;18:639-643.
38. Selby PL, Young MJ, Boulton AJM. Bisphoshonates: a New treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994;11:28-31.
39. Hughes DE, et al. The cellular mechanism of action of bisphosphonates. Drugs Exp Clin Res 1991;17:109-114.